Inoa | Tirzepatide i ka pauku |
ʻO Menu ka hoʻomaʻemaʻe | 99% |
Helehelena | Keʻokeʻo keʻokeʻo keʻokeʻo keʻokeʻo |
Papaho | Subcutaneous injection |
Nui | 10mg, 15mg, 20mg, 30mg |
Wai | 3.0% |
KA MANAWA | Ka mālamaʻana i ka maʻi diabetes, hoʻomaikaʻi i ke kahe koko koko |
ʻO Tirzepatide kahi mea iʻikeʻoleʻiaʻo Ivel Gullunotrop Mālamaʻia i ka hapanui o ka hana a me ka momona a me ka momona a me nā cirrhotic non-almoplic steatothepatitis. Ua hoʻolālāʻia ka phase 3 1-5 no ka hoʻokolokolo hoʻokolokolo hoʻokolokolo e loiloi i ka hopena a me ka palekana o keʻano he nui. Hoʻohanaʻia ka hoʻohanaʻana i ka Tirzepatide i nā haʻawina Clinical e pili ana i nā hōʻemiʻana i ka hemoglobin i hoʻohuiʻia me keʻano o ke koko. -6 triglycerides. Ua hana maikaʻiʻiaʻo Tirzepatide, me kahi haʻahaʻa haʻahaʻa o ka hypoglycaemia i ka wā i hoʻohanaʻia me kaʻole o ka palekana palekana Wahi a nā hōʻike hōʻike mai kēia mau hoʻokolohua lapaʻau e hōʻike ana i kēlā me ka nui o ka tirzepatide i kahi manawa hou no ka nui o ka hemoglobin a me ke kino o ke kino.